DESCRIPTION OF THE STIMULATED PLEURAL ADHESION FORMATION



如何引用文章

全文:

全文:

Aim. To describe the stimulated pleural adhesion formation Material and Methods. 270 nonlinear rats (males) were modeled by the pleural empyema, followed by the Platelet-Rich Plasma Therapy (PRP Therapy). For this purpose, 1 ml of plasma enriched with platelets was injected into the pleural cavity. The rats were sacrificed on the 30th day after the injection. Results and Discussion. All rats of the pleural empyema model showed the residual pleural cavities of different size filled with the purulent content. Microscopically, the residual cavities showed the diffuse leukocyte infiltration, focal destruction of mesothelium, and an accumulation of tissue detritus before PRP Therapy. With PRP Therapy, a total obliteration of empyema cavities was detected in 41 (30.4%) of the experimental animals. By the 30th day after plasma injection, the residual cavities were almost completely filled with the collagen fibers with a low number of lymphocytes and capillaries in the formed adhesions. Conclusions. Stimulation of the pleural adhesion formation by the pleural injection of plasma enriched with platelets is an effective therapy based on the local development of multiple adhesions which fill the residual cavity. An additional advantage is a safety of the biological substrate used in this method of treatment.
×

作者简介

A. Kalashnikov

Volgograd Medical State University

Email: cos@pmedpharm.ru
Рyatigorsk Medical Pharmaceutical Institute

D. Salimov

P. V. Mandryka Medical Educational and Scientific Clinical Centre

S. Aydaeva

Volgograd Medical State University

Рyatigorsk Medical Pharmaceutical Institute

参考

补充文件

附件文件
动作
1. JATS XML

版权所有 © Kalashnikov A.V., Salimov D.S., Aydaeva S.S., 2018

Creative Commons License
此作品已接受知识共享署名-非商业性使用-禁止演绎 4.0国际许可协议的许可。

Периодический печатный журнал зарегистрирован как СМИ Федеральной службой по надзору в сфере связи, информационных технологий и массовых коммуникаций (Роскомнадзор): 0110212 от 08.02.1993.
Сетевое издание зарегистрировано как СМИ Федеральной службой по надзору в сфере связи, информационных технологий и массовых коммуникаций (Роскомнадзор): ЭЛ № ФС 77 - 84733 от 10.02.2023.